Age, years
|
73.4 (7.6)
|
71.8 (7.4)
|
0.32
|
Education, years
|
5.7 (5.4)
|
5.4 (5.1)
|
0.4
|
Sex, male/female
|
42/34
|
11/17
|
0.186
|
ApoE ε4 allele-positive cases, n (%)
|
29 (38.5%)
|
13 (46.42%)
|
0.503
|
Use of rivastigmine/donepezil
|
37/39
|
17/11
|
0.377
|
Mini Mental State Examination score
|
21.6 (5.7)
|
20.6 (5.1)
|
0.286
|
CVVLT verbal memory (9)
|
Trials 1–4 total
|
19.6 (7.08)
|
18.0 (6.9)
|
0.173
|
30-second free recall
|
4.78 (2.6)
|
4.18 (2.73)
|
0.265
|
10-minute free recall
|
3.52 (3.3)
|
3.21(2.8)
|
0.935
|
Visual memory
|
Modified Rey-Osterrieth recall (17)
|
4.7 (5.2)
|
4.04 (4.16)
|
0.67
|
Visuospatial function
|
Modified Rey-Osterrieth copy (17)
|
14.3 (5.0)
|
14.9 (4.6)
|
0.896
|
Visual Object and Space Perception Battery (10)
|
6.4 (3.16)
|
5.8 (3.45)
|
0.446
|
Speech and language ability
|
Semantic fluency: animal (1 minute)
|
11.2 (4.63)
|
10.33 (5.74)
|
0.387
|
Boston Naming Test (15)
|
12.8 (3.0)
|
11.6 (2.8)
|
0.04a
|
Comprehension (4)
|
2.8 (0.9)
|
2.3 (1.2)
|
0.053
|
Executive function
|
Digit backward
|
3.2 (1.3)
|
3.2 (1.1)
|
0.758
|
Stroop interference correct (1 minute)
|
25.9 (13.1)
|
21.6 (15.7)
|
0.178
|
Design fluency
|
4.31 (2.8)
|
4.5 (3.8)
|
0.612
|
Trail Making Test time (<120 seconds)
|
99.2 (32.3)
|
93.0 (37.9)
|
0.446
|
Correct line in Trail Making Test (14)
|
7.1 (5.4)
|
7.6 (5.6)
|
0.742
|